Back to newsroom

News

Gameto Announces Patient Experience Data Demonstrating Investigational In Vitro Maturation Solution Well Tolerated with Higher Patient Satisfaction Rates than Conventional Fertility Stimulation

Written By:

Last updated:

April 2, 2024

Share

Related Articles

News

Gameto Secures $33M To Support Clinical Development of Fertility Treatment

Read article

News

Gameto founder talks menopause and female healthspan extension

Read article

REPROCELL Announces License Agreement with Gameto for the Advancement of its Program to Improve Assisted Fertility using iPSCs

Read article